First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib

Dominic James, Kate Smith, Allan Jordan, Emma Fairweather, Louise Griffiths, Nicola Hamilton, James Hitchin, Colin Hutton, Stuart Jones, Paul Kelly, Alison Mcgonagle, Helen Small, Alexandra Stowell, Julie Tucker, Ian Waddell, Bohdan Waszkowycz, Donald Ogilvie

Research output: Contribution to journalArticlepeer-review

Abstract

The enzyme poly(ADP-ribose) glycohydrolase (PARG) performs a critical role in the repair of DNA single strand breaks (SSBs). However, a detailed understanding of its mechanism of action has been hampered by a lack of credible, cell-active chemical probes. Herein, we demonstrate inhibition of PARG with a small molecule, leading to poly(ADP-ribose) (PAR) chain persistence in intact cells. Moreover, we describe two advanced, and chemically distinct, cell-active tool compounds with convincing on-target pharmacology and selectivity. Using one of these tool compounds, we demonstrate pharmacology consistent with PARG inhibition. Further, while the roles of PARG and poly(ADP-ribose) polymerase (PARP) are closely intertwined, we demonstrate that the pharmacology of a PARG inhibitor differs from that observed with the more thoroughly studied PARP inhibitor olaparib. We believe that these tools will facilitate a wider understanding of this important component of DNA repair and may enable the development of novel therapeutic agents exploiting the critical dependence of tumors on the DNA damage response (DDR).

Original languageEnglish
Pages (from-to)3179-3190
Number of pages12
JournalACS chemical biology
Volume11
Issue number11
Early online date30 Sept 2016
DOIs
Publication statusPublished - 18 Nov 2016

Research Beacons, Institutes and Platforms

  • Manchester Cancer Research Centre

Fingerprint

Dive into the research topics of 'First-in-Class Chemical Probes against Poly(ADP-ribose) Glycohydrolase (PARG) Inhibit DNA Repair with Differential Pharmacology to Olaparib'. Together they form a unique fingerprint.

Cite this